Theralink Technologies
Biotechnology, W 6th Ave, Golden, , 80401, Colorado, 15000, United States, 11-50 Employees
Phone Number: 88********
Who is THERALINK TECHNOLOGIES
At Theralink Technologies, our approach is based on more than 16 years of research and development. Our research indicates that genomic and transcriptomic information alone provides an in...
Read More
-
Headquarters: 15000 W 6th Ave, Golden, Colorado, 80401, United States
-
Date Founded: 2005
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Mick Ruxin
Email
Phone
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from THERALINK TECHNOLOGIES
Theralink Technologies Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Theralink Technologies
Answer: Theralink Technologies's headquarters are located at W 6th Ave, Golden, , 80401, Colorado, 15000, United States
Answer: Theralink Technologies's phone number is 88********
Answer: Theralink Technologies's official website is https://theralink.com
Answer: Theralink Technologies's revenue is $10 Million to $25 Million
Answer: Theralink Technologies's SIC: 2834
Answer: Theralink Technologies has 11-50 employees
Answer: Theralink Technologies is in Biotechnology
Answer: Theralink Technologies contact info: Phone number: 88******** Website: https://theralink.com
Answer: At Theralink Technologies, our approach is based on more than 16 years of research and development. Our research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions. Our phosphoproteomic RPPA approach is the only commercial platform that quantifies the activation state (phosphorylation) of drug target proteins and their downstream signaling partners within the tumor tissue. Our advanced technology exploits our understanding of the drug-receptor and drug-protein interactions that drive treatment responses. The Theralink assay has been developed to provide physicians with a treatment decision support tool to assist in selecting therapies that are more likely to result in responses to treatment. Our large panel of new protein biomarkers targets therapeutic molecular inhibitors including current FDA approved therapies and certain investigational drugs, making Theralink an invaluable tool for oncologists and biopharma clinical trials.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month